Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by JLGeminion Dec 20, 2010 7:47pm

234 Views

Post# 17873569

RE: RE: People!

Cravenraven, you can not even come up with an original line. Your line comes from The Shooter. The movie stared Mark Wahlberg. Here is a reference to the quote: https://www.imdb.com/title/tt0822854/quotes?qt0342183. The book was written by Stephen Hunter and is called Point of Impact. The book starts with an impressive hunting scene that loops back into the plot. I find it interesting that fiction portrays real events and now real events protray fiction.

Bullboard Posts

Three stocks with strong income statements to buy right now